Jannine G. Truong, Ph.D. - Publications
Affiliations: | 2004 | University of Utah, Salt Lake City, UT |
Area:
Pharmacology, Neuroscience BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2008 | Chu PW, Seferian KS, Birdsall E, Truong JG, Riordan JA, Metcalf CS, Hanson GR, Fleckenstein AE. Differential regional effects of methamphetamine on dopamine transport. European Journal of Pharmacology. 590: 105-10. PMID 18599036 DOI: 10.1016/J.Ejphar.2008.05.028 | 0.601 | |||
2006 | Rau KS, Truong JG, Wilkins DG, Fleckenstein AE, Hanson GR. Age-dependent effects of methamphetamine on VMAT-2. Annals of the New York Academy of Sciences. 1074: 154-9. PMID 17105913 DOI: 10.1196/Annals.1369.015 | 0.52 | |||
2005 | Truong JG, Wilkins DG, Baudys J, Crouch DJ, Johnson-Davis KL, Gibb JW, Hanson GR, Fleckenstein AE. Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicity. The Journal of Pharmacology and Experimental Therapeutics. 314: 1087-92. PMID 15901804 DOI: 10.1124/Jpet.105.085951 | 0.621 | |||
2004 | Truong JG, Newman AH, Hanson GR, Fleckenstein AE. Dopamine D2 receptor activation increases vesicular dopamine uptake and redistributes vesicular monoamine transporter-2 protein. European Journal of Pharmacology. 504: 27-32. PMID 15507217 DOI: 10.1016/J.Ejphar.2004.09.049 | 0.63 | |||
2004 | Truong JG, Hanson GR, Fleckenstein AE. Apomorphine increases vesicular monoamine transporter-2 function: implications for neurodegeneration. European Journal of Pharmacology. 492: 143-7. PMID 15178358 DOI: 10.1016/J.Ejphar.2004.03.060 | 0.668 | |||
2004 | Johnson-Davis KL, Truong JG, Fleckenstein AE, Wilkins DG. Alterations in vesicular dopamine uptake contribute to tolerance to the neurotoxic effects of methamphetamine. The Journal of Pharmacology and Experimental Therapeutics. 309: 578-86. PMID 14747615 DOI: 10.1124/Jpet.103.062695 | 0.636 | |||
2003 | Truong JG, Rau KS, Hanson GR, Fleckenstein AE. Pramipexole increases vesicular dopamine uptake: implications for treatment of Parkinson's neurodegeneration. European Journal of Pharmacology. 474: 223-6. PMID 12921866 DOI: 10.1016/S0014-2999(03)02080-6 | 0.642 | |||
Show low-probability matches. |